Mezzion Pharma Co.,Ltd. (KOSDAQ:140410)

Mezzion Pharma Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 15, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,115,699	924,369	1,153,908	347,646	1,932,235	1,563,338
Market Cap Growth	-14.29%	-19.89%	231.92%	-82.01%	23.60%	-6.13%
Enterprise Value	1,096,099	891,105	1,093,258	314,521	1,903,261	1,542,499
Last Close Price	37050.00	30850.00	39000.00	13000.00	72366.67	58600.00
Forward PE	-	-	-	-	-	151.06
PS Ratio	132.71	107.34	36.38	11.31	72.49	54.60
PB Ratio	25.79	20.07	18.78	13.25	30.77	27.52
P/TBV Ratio	26.79	20.80	19.29	14.12	31.59	28.33
EV/Sales Ratio	130.38	103.48	34.47	10.24	71.41	53.87
EV/FCF Ratio	-52.20	-	-	-	-	-
Debt / Equity Ratio	0.03	0.04	0.04	0.04	0.07	0.09
Asset Turnover	0.11	0.10	0.43	0.45	0.33	0.43
Inventory Turnover	1.19	1.20	3.82	3.01	2.44	3.26
Quick Ratio	0.85	1.12	2.12	1.35	2.72	3.35
Current Ratio	1.33	1.57	2.51	1.76	3.47	3.91
Return on Equity (ROE)	-45.26%	-36.23%	-29.03%	-81.54%	-22.75%	-27.85%
Return on Assets (ROA)	-10.84%	-10.76%	-12.39%	-21.14%	-13.16%	-7.00%
Return on Capital (ROIC)	-16.54%	-16.05%	-19.90%	-30.89%	-16.27%	-8.69%
Earnings Yield	-2.05%	-2.11%	-1.10%	-10.44%	-0.70%	-0.89%
FCF Yield	-1.88%	-2.06%	-1.00%	-3.69%	-0.80%	-0.52%
Buyback Yield / Dilution	-3.15%	-5.62%	-5.63%	-0.17%	-2.63%	-0.11%

Updated Mar 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.